Shine-On BioMedical Co.,Ltd. (TPEX: 6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.50
-0.50 (-0.75%)
Jan 22, 2025, 2:49 PM CST
4.72%
Market Cap 3.31B
Revenue (ttm) 9.52M
Net Income (ttm) -70.83M
Shares Out 49.80M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,000
Average Volume 45,058
Open 66.70
Previous Close 67.00
Day's Range 66.30 - 66.80
52-Week Range 61.10 - 70.50
Beta -0.09
RSI 48.71
Earnings Date Apr 18, 2025

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 19
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.